Anand Patel to Clinical Trials as Topic
This is a "connection" page, showing publications Anand Patel has written about Clinical Trials as Topic.
Connection Strength
0.132
-
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
Score: 0.132
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.